Abstract
Immunoliposomes have emerged as attractive drug targeting vehicles for cancer treatment.
This review presents the recent advances in the design of immunoliposomes encapsulating a
variety of chemotherapeutic agents. We provided an overview of different routes that can be used
to conjugate antibodies to the surfaces of liposomes, as well as several examples of stimuliresponsive
immunoliposome systems and their therapeutic potential for cancer treatment.
Keywords:
Cancer, targeted drug delivery, antibodies, antibody fragments, immunoliposomes, receptor upregulation.
Graphical Abstract
[2]
Tekade R K. Basic fundamentals of drug delivery In: Academic Press: USA 2019.
[7]
Sagnella S, Drummond C. Drug Delivery: A Nanomedicine Approach. Aust Biochem 2012; 43(3): 5-20.
[28]
Coico R, Sunshine G, Benjamini E. Immunology : a short course. Wiley-Liss 2003.
[32]
Hazra MS, Ray S. Surface Modification of Liposomal Vaccines by Peptide Conjugation. J Pharm Sci Technol 2011; 1(1): 41-7.
[33]
Hermanson G T. Bioconjugate techniques. In: Thermoscientific: USA 2018.
[38]
Sen Gupta AS, von Recum H A. Bioconjugation strategies: Lipids, liposomes, polymersomes, and microbubbles. In: Wiley: USA 2014.
[45]
Hermanson GT. Bioconjugate techniques. Academic Press: USA 2008.
[47]
Aslam M, Dent A. Bioconjugation : protein coupling techniques for the biomedical sciences. Macmillan Reference: USA 1998.
[48]
Wong SS. Chemistry of protein conjugation and cross-linking. CRC Press: USA 1991.
[87]
Ruan H, Hao S, Young P, Zhang H. Targeting cathepsin B for cancer therapies.Horizons in Cancer Research. Nova Science Publishers. In: Inc USA. 2015; 56: pp. 23-39.